For best results when printing this announcement, please click on the linkbelow:
  http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130124:nPnCL46143
 DUBAI, United Arab Emirates,  Jan. 24, 2013  /PRNewswire/ -- At the 38th edition of the Arab Health Congress and Exhibition, 28-31 January, at the DubaiInternational Convention & Exhibition Centre, Elekta (booth #S2E30) willhighlight its comprehensive range of advanced cancer care solutions, includingElekta Compact, Elekta Synergy  and Elekta Infinity for conventional radiationtherapy, and Leksell Gamma Knife Perfexion for stereotactic neurosurgery. Inaddition, Elekta will showcase its new Agility 160-leaf multi-leaf collimatorand sophisticated brachytherapy solutions, which are used by 75 percent ofbrachytherapy clinics in the  Middle East  region.  Elekta has shipped Agility to sites in more than 20 countries - including  SaudiArabia  - with clinics in  Iraq  and  Turkey  scheduled to receive shipment in2013. Clinicians at these sites are reporting remarkable gains in beam-shapingability, precision and delivery speed. Shorter treatment times have resulted inincreased patient comfort and convenience as well as an improved ability forcaregivers to treat more patients daily.  "According to the World Health Organization (WHO), cancer is a leading cause ofdeath worldwide, and the fourth-ranked cause of death in the  Middle East region. The largest increase in cancer incidence in the WHO regions in the next15 years is likely to be in the wider  Middle East  region," says  Nabil EliasRomanos, Elekta's Vice President,  Eastern Europe  and  Middle East. "To meetthis need, we have collaborated with leading hospitals and research institutionsto develop a solution that can increase patient throughput while deliveringexceptional precision. Agility is designed to meet these needs.""Breaking new ground, Elekta has actively supported  Iraq  clinics' and Ministryof Health efforts to increase accessibility to advanced cancer managementtechnology, as the country rebuilds its healthcare infrastructure after nearlythree decades of wars, embargoes and unrest," Romanos adds. "We particularly arepleased that the prestigious Medical City in  Baghdad  chose Elekta as its mainpartner in providing cancer care to the Iraqi people, and for their hosting of aconference in  Baghdad  on Leksell Gamma Knife Perfexion. This symposiumpreceded the  Iraq-Sweden  governmental investment conference, at which Elektawas selected to present as the health care success story in  Iraq."Another example is the groundbreaking new cancer facility in the Maymunadistrict of western Maysan province that will be a center of attraction insouthern  Iraq  and the country as a whole. To equip this clinic, Elekta willprovide two Elekta Synergy Platform systems, MOSAIQ Oncology Information Systemand treatment planning technology, which will become clinical in the spring of2013.  At the Radiation Oncology Center in Suleimaniyah,  Kurdistan, Elekta - the onlyradiotherapy provider in this part of  Iraq  - installed the clinic's secondElekta Synergy system. The added capacity will help ease the demand for cancercare services in a region of more than 4.5 million inhabitants that drawspatients from other parts of  Iraq, and where a six-month wait for treatment wascommon.  Elekta also has committed to helping the country's cancer care infrastructure byproviding brachytherapy technology, as well as education and training services.  *Agility and Elekta Compact are not available for sale or distribution in allregions. Please contact your local Elekta representative or authorizeddistributor for further details.For further information, please contact:Johan Andersson Melbi, Director, Investor Relations,  Elekta ABTel: +46 702 100 451, email:  johan.anderssonmelbi@elekta.com  Time zone: CET: Central European TimeMichelle Joiner, Director, Global Public Relations and Brand Management, Elekta Tel: +1 770-670-2447, email:  michelle.joiner@elekta.comTime zone: ET: Eastern TimeAbout ElektaElekta is a human care company pioneering significant innovations and clinicalsolutions for treating cancer and brain disorders. The company developssophisticated, state-of-the-art tools and treatment planning systems forradiation therapy, radiosurgery and brachytherapy, as well as workflow enhancingsoftware systems across the spectrum of cancer care. Stretching the boundariesof science and technology, providing intelligent and resource-efficientsolutions that offer confidence to both healthcare providers and patients,Elekta aims to improve, prolong and even save patient lives.  Today, Elekta solutions in oncology and neurosurgery are used in over 6,000hospitals worldwide. Elekta employs around 3,400 employees globally. Thecorporate headquarters is located in  Stockholm, Sweden, and the company islisted on the Nordic Exchange under the ticker EKTAb. Website:  
  www.elekta.com.
    SOURCE  Elekta